Hikma Pharmaceuticals Financial Overview
Hikma Pharmaceuticals's market cap is currently $4.43B. The company's EPS TTM is $2.168; its P/E ratio is 11.97; and it has a dividend yield of 4.12%. Hikma Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
